Irith Wiegand

8.8k total citations · 1 hit paper
27 papers, 6.5k citations indexed

About

Irith Wiegand is a scholar working on Molecular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Irith Wiegand has authored 27 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Medicine, 11 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Irith Wiegand's work include Antibiotic Resistance in Bacteria (22 papers), Bacterial biofilms and quorum sensing (10 papers) and Urinary Tract Infections Management (8 papers). Irith Wiegand is often cited by papers focused on Antibiotic Resistance in Bacteria (22 papers), Bacterial biofilms and quorum sensing (10 papers) and Urinary Tract Infections Management (8 papers). Irith Wiegand collaborates with scholars based in Canada, Germany and Spain. Irith Wiegand's co-authors include Robert E. W. Hancock, Kai Hilpert, Manjeet Bains, Lucía Fernández, W. James Gooderham, José Luis Martínez, Jorge Olivares‐Pacheco, Carolina Alvarez‐Ortega, Joseph B. McPhee and Joerg Overhage and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Bacteriology.

In The Last Decade

Irith Wiegand

27 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances

2008 4.7k citations Irith Wiegand, Kai Hilpert et al. Nature Protocols profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Irith Wiegand Canada	21	2.7k	1.9k	1.7k	950	949	27	6.5k
Ian Chopra United Kingdom	37	3.2k 1.2×	2.2k 1.1×	973 0.6×	738 0.8×	919 1.0×	89	8.2k
Alex J. O’Neill United Kingdom	43	2.8k 1.0×	1.4k 0.7×	854 0.5×	427 0.4×	766 0.8×	98	5.9k
Jessica M. A. Blair United Kingdom	24	2.1k 0.8×	2.4k 1.3×	674 0.4×	669 0.7×	531 0.6×	55	5.7k
Bonnie Marshall United States	21	1.7k 0.6×	1.9k 1.0×	657 0.4×	950 1.0×	515 0.5×	38	6.2k
Daniel J. Dwyer United States	17	4.3k 1.6×	2.2k 1.1×	660 0.4×	550 0.6×	481 0.5×	23	7.9k
Kai Hilpert Germany	31	4.3k 1.6×	904 0.5×	3.8k 2.2×	1.1k 1.1×	1.5k 1.6×	71	8.4k
Françoise Van Bambeke Belgium	54	3.6k 1.3×	3.0k 1.5×	1.2k 0.7×	529 0.6×	742 0.8×	253	9.4k
Lucía Fernández Spain	36	2.3k 0.8×	1.5k 0.8×	947 0.6×	475 0.5×	219 0.2×	104	5.0k
Christian Melander United States	49	4.0k 1.5×	1.3k 0.7×	1.2k 0.7×	320 0.3×	1.8k 1.9×	179	6.8k
M. Stephen Trent United States	48	4.3k 1.6×	3.0k 1.5×	1.4k 0.8×	987 1.0×	421 0.4×	125	9.1k

Countries citing papers authored by Irith Wiegand

Since Specialization

Citations

This map shows the geographic impact of Irith Wiegand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irith Wiegand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irith Wiegand more than expected).

Fields of papers citing papers by Irith Wiegand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irith Wiegand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irith Wiegand. The network helps show where Irith Wiegand may publish in the future.

Co-authorship network of co-authors of Irith Wiegand

This figure shows the co-authorship network connecting the top 25 collaborators of Irith Wiegand. A scholar is included among the top collaborators of Irith Wiegand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irith Wiegand. Irith Wiegand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Turjeman‬‏, ‪Adi, Tanya Babich, Miquel Pujol, et al.. (2021). Risk factors for enterococcal urinary tract infections: a multinational, retrospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 40(9). 2005–2010. 6 indexed citations

Babich, Tanya, Noa Eliakim‐Raz, ‪Adi Turjeman‬‏, et al.. (2021). Risk factors for hospital readmission following complicated urinary tract infection. Scientific Reports. 11(1). 6926–6926. 7 indexed citations

Gomila‐Grange, Aina, Jordi Carratalà, Noa Eliakim‐Raz, et al.. (2019). Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study. Antimicrobial Resistance and Infection Control. 8(1). 198–198. 36 indexed citations

Gomila‐Grange, Aina, Jordi Carratalà, Noa Eliakim‐Raz, et al.. (2018). Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study. SHILAP Revista de lepidopterología. 2 indexed citations

Vallejo‐Torres, Laura, Miquel Pujol, Evelyn Shaw, et al.. (2018). Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study. BMJ Open. 8(4). e020251–e020251. 48 indexed citations

Gomila‐Grange, Aina, Evelyn Shaw, Jordi Carratalà, et al.. (2018). Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections. Antimicrobial Resistance and Infection Control. 7(1). 111–111. 47 indexed citations

Carratalà, Jordi, Noa Eliakim‐Raz, Evelyn Shaw, et al.. (2018). Risk factors and prognosis of complicated urinary tract infections caused by <em>Pseudomonas aeruginosa</em> in hospitalized patients: a retrospective multicenter cohort study. Infection and Drug Resistance. Volume 11. 2571–2581. 33 indexed citations

Shaw, Evelyn, Christiane Vank, Sally Grier, et al.. (2016). Retrospective observational study to assess the clinical management and outcomes of hospitalised patients with complicated urinary tract infection in countries with high prevalence of multidrug resistant Gram-negative bacteria (RESCUING). BMJ Open. 6(7). e011500–e011500. 6 indexed citations

Alvarez‐Ortega, Carolina, Irith Wiegand, Jorge Olivares‐Pacheco, Robert E. W. Hancock, & José Luis Martínez. (2011). The intrinsic resistome ofPseudomonas aeruginosato β-lactams. Virulence. 2(2). 144–146. 75 indexed citations

10.

Alvarez‐Ortega, Carolina, Irith Wiegand, Jorge Olivares‐Pacheco, Robert E. W. Hancock, & José Luis Martínez. (2010). Genetic Determinants Involved in the Susceptibility of Pseudomonas aeruginosa to β-Lactam Antibiotics. Antimicrobial Agents and Chemotherapy. 54(10). 4159–4167. 129 indexed citations

11.

Breidenstein, Elena B. M., et al.. (2008). Complex Ciprofloxacin Resistome Revealed by Screening a Pseudomonas aeruginosa Mutant Library for Altered Susceptibility. Antimicrobial Agents and Chemotherapy. 52(12). 4486–4491. 131 indexed citations

12.

Wiegand, Irith, Kai Hilpert, & Robert E. W. Hancock. (2008). Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature Protocols. 3(2). 163–175. 4683 indexed citations breakdown →

13.

Gooderham, W. James, Manjeet Bains, Joseph B. McPhee, Irith Wiegand, & Robert E. W. Hancock. (2008). Induction by Cationic Antimicrobial Peptides and Involvement in Intrinsic Polymyxin and Antimicrobial Peptide Resistance, Biofilm Formation, and Swarming Motility of PsrA in Pseudomonas aeruginosa. Journal of Bacteriology. 190(16). 5624–5634. 61 indexed citations

14.

Wiegand, Irith, et al.. (2007). Resistance Mechanisms of Multiresistant Pseudomonas aeruginosa Strains from Germany and Correlation with Hypermutation. Antimicrobial Agents and Chemotherapy. 51(11). 4062–4070. 149 indexed citations

15.

Wiegand, Irith, Heinrich K. Geiss, Dietrich Mack, Enno Stürenburg, & Harald Seifert. (2007). Detection of Extended-Spectrum Beta-Lactamases among Enterobacteriaceae by Use of Semiautomated Microbiology Systems and Manual Detection Procedures. Journal of Clinical Microbiology. 45(4). 1167–1174. 138 indexed citations

16.

Kadlec, Kristina, Irith Wiegand, Corinna Kehrenberg, & Štefan Schwarz. (2007). Studies on the mechanisms of β-lactam resistance in Bordetella bronchiseptica. Journal of Antimicrobial Chemotherapy. 59(3). 396–402. 28 indexed citations

17.

Ashour, Mohamed Seif El-Din, et al.. (2006). First description of CTX-M β-lactamase-producing clinical Escherichia coli isolates from Egypt. International Journal of Antimicrobial Agents. 27(6). 545–548. 66 indexed citations

18.

Schiefer, Andrea, et al.. (2005). Biochemical and genetic characterization of the β-lactamases of Y. aldovae, Y. bercovieri, Y. frederiksenii and ‘Y. ruckeri’ strains. International Journal of Antimicrobial Agents. 25(6). 496–500. 12 indexed citations

19.

Wiegand, Irith. (2004). Effect of inoculum density on susceptibility of Plesiomonas shigelloides to cephalosporins. Journal of Antimicrobial Chemotherapy. 54(2). 418–423. 9 indexed citations

20.

Wiegand, Irith, et al.. (1998). β-Lactamase induction and cell wall recycling in gram-negative bacteria. Drug Resistance Updates. 1(4). 223–226. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact